Annual awards program recognizes excellence in editorial, marketing, and product success in the specialized information industry.
Cannabis Science and Technology®, a multimedia platform that focuses on educating the legal cannabis industry about the science and technology of analytical testing, quality control, extraction, and cultivation, recently won third place in the “Best Interview or Profile of Someone in Your Industry” category during the 41st Annual SIPAwards virtual ceremony on June 2.
“It is an incredible honor that Cannabis Science and Technology® has been recognized as a finalist in the 2020 SIPAwards,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of Cannabis Science and Technology®. “This amazing recognition clearly demonstrates that we are producing top-notch content that caters to our audience, and we are grateful for this opportunity to showcase our work.”
The Cannabis Science and Technology® entry titled “Dr. Sue Sisley: Advocating for Medical Cannabis Research, Patients, and Reform” highlights the pioneering research in the U.S. medical cannabis industry that Dr. Sue Sisley has been conducting, as well as her fight for quality cannabis samples to conduct her clinical trials. Sisley’s research has focused on veterans, professional athletes, post-traumatic stress disorder, pain management, and opioid addiction.
Since 1978, the SIPAwards have recognized excellence in editorial, marketing and product success in the specialized information industry. This year, the awards ceremony celebrated niche publishing excellence throughout the industry with 27 categories.
View a full list of winners here.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.